Genes and osteoporosis – editorial

Czech version

Authors: V. Palička
Authors‘ workplace: Osteocentrum, Ústav klinické biochemie a diagnostiky LF UK a FN Hradec Králové, přednosta prof. MU Dr. Vladimír Palička, CSc., dr. h. c.
Published in: Vnitř Lék 2011; 57(1): 27-28
Category: Editorials

Sources

1. Chmelařová M, Palička V. Hypermetylace DNA u ovariálního karcinomu. Klin Biochem Metab 2010; 18: 214– 218.

2. David V, Quarles LD. ASARM Mineralization Hypothesis: A Bridge Too Far? J Bone Miner Res 2010; 25: 692– 694.

3. Duncan EL, Brown MA. Genetic Determinants of Bone Density and Fracture Risk – State of the Art and Future Directions. J Clin Endocrinol Metab 2010; 95: 2576– 2587.

4. Earl SC, Harvey N, Cooper C. The Epigenetic Regulation of Bone Mass. IBMS BoneKEy 2010; 7: 54– 62.

5. Ferrari S. Human genetics of osteoporosis. Best Pract Res Clin Endocr Metab 2008; 22: 723– 735.

6. Kato S, Inoue K, Youn MY. Emergence of the Osteo‑ Epigenome in Bone Biology. IBMS BoneKEy 2010; 7, 314– 324.

7. Marini F, Falchetti A, Silvestri S et al. Modulatory effect of farnesyl pyropshosphate synthase (FDPS) rs2297480 polymorphism on the response to long‑term amino‑ bisphosphonate treatment in postmenopausal osteoporosis. Curr Med Res Opin 2008; 24: 2609– 2615.

8. Reppe S, Refvem H, Gautvik VT et al. Eight genes are highly associated with BMD variation in postmenopausal Caucasian women. Bone 2010; 46: 604– 612.

9. Zhang YP, Deng FY, Chen Y et al. Replication study of candidate genes/ loci associated with osteoporosis based on genome‑ wide screening. Osteoporosis Int 2010; 21: 785– 795.